ORGANIC ELECTROLUMINESCENT DEVICE
    6.
    发明申请
    ORGANIC ELECTROLUMINESCENT DEVICE 有权
    有机电致发光器件

    公开(公告)号:US20160155943A1

    公开(公告)日:2016-06-02

    申请号:US14937314

    申请日:2015-11-10

    IPC分类号: H01L51/00 C09K11/02

    摘要: An organic EL device including an anode; an emission layer; an anode-side hole transport layer between the anode and the emission layer, the anode-side hole transport layer including an anode-side hole transport material and being doped with an electron accepting material; an intermediate hole transport layer between the anode-side hole transport layer and the emission layer, the intermediate hole transport layer including an intermediate hole transport material; and an emission layer-side hole transport layer between the intermediate hole transport layer and the emission layer, the emission layer-side hole transport layer being adjacent to the emission layer, wherein the emission layer-side hole transport layer includes an emission layer-side hole transport material represented by the following Formula 1:

    摘要翻译: 一种包括阳极的有机EL器件; 发射层; 在阳极和发射层之间的阳极侧空穴传输层,阳极侧空穴传输层包括阳极侧空穴传输材料并掺杂有电子接受材料; 阳极侧空穴传输层和发光层之间的中间空穴传输层,中间空穴传输层包括中间空穴传输材料; 以及在中间空穴传输层和发光层之间的发光层侧空穴传输层,发光层侧空穴传输层与发光层相邻,发光层侧空穴传输层包含发光层侧空穴传输层 由下式1表示的空穴输送材料:

    SELECTIVE SIGMA-1 RECEPTOR LIGANDS
    9.
    发明申请
    SELECTIVE SIGMA-1 RECEPTOR LIGANDS 有权
    选择性SIGMA-1受体配体

    公开(公告)号:US20130102571A1

    公开(公告)日:2013-04-25

    申请号:US13707418

    申请日:2012-12-06

    摘要: The invention provides compounds of the formulas described herein and compositions thereof. The invention further provides methods of using the compounds and compositions. The compounds of the invention can provide high affinity binding to sigma-1 receptors in a mammal. The compounds can exhibit selectivity for the sigma-1 receptor over the sigma-2 receptor. The compounds and compositions of the invention can also be used to treat conditions that involve the sigma-1 receptor, such as addiction, cardiovascular conditions, and cancer, for example, cancer of the breast, lung, prostate, ovarian, colorectal, or the CNS.

    摘要翻译: 本发明提供了本文所述的化合物及其组合物。 本发明还提供了使用化合物和组合物的方法。 本发明的化合物可以提供与哺乳动物中σ-1受体的高亲和力结合。 该化合物可显示σ-2受体超过σ-2受体的选择性。 本发明的化合物和组合物还可用于治疗涉及σ-1受体的病症,例如成瘾,心血管病症和癌症,例如乳腺癌,肺癌,前列腺癌,卵巢癌,结肠直肠癌或 中枢神经系统